Literature DB >> 1555746

The role of interferon gamma in the pathogenesis of Crohn's disease.

T Sasaki1, N Hiwatashi, H Yamazaki, M Noguchi, T Toyota.   

Abstract

To investigate the role of interferon gamma in the pathogenesis of Crohn's disease, we examined the interferon gamma levels of serum, supernatant of cultured peripheral blood mononuclear cells activated by phytohemagglutinin, and medium of organ culture of colonic mucosa in Crohn's disease. Serum interferon gamma levels in Crohn's disease, especially in active or non-resected Crohn's disease, were more elevated than those in normal subjects. In contrast, the production of interferon gamma by peripheral blood mononuclear cells was reduced in Crohn's disease. In some patients, interferon gamma levels of organ culture medium of colonic mucosal tissue specimens were elevated. When peripheral blood mononuclear cells were preincubated for 72 hours, interferon gamma production in Crohn's disease increased from 23.8% to 62.3% in comparison to levels in healthy controls. These results indicate that elevated serum interferon gamma in Crohn's disease may originate from the intestine, and interferon gamma may be related to the immune reaction and inflammation in the intestine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555746

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  35 in total

1.  Organ culture of human rectal mucosa.

Authors:  G L Eastwood; J S Trier
Journal:  Gastroenterology       Date:  1973-03       Impact factor: 22.682

2.  Recombinant human gamma-interferon induces human monocyte polykaryon formation.

Authors:  J B Weinberg; M M Hobbs; M A Misukonis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

3.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.

Authors:  V E Kelley; W Fiers; T B Strom
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.

Authors:  J Auböck; D Niederwieser; N Romani; P Fritsch; C Huber
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

6.  Cytokine-induced generation of multinucleated giant cells in vitro requires interferon-gamma and expression of LFA-1.

Authors:  J Möst; H P Neumayer; M P Dierich
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

7.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens.

Authors:  P Erb; M Feldmann
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

10.  Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity.

Authors:  P S Steeg; R N Moore; H M Johnson; J J Oppenheim
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  19 in total

1.  Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.

Authors:  Gisela Paul; Ronald R Marchelletta; Declan F McCole; Kim E Barrett
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  T cell protein tyrosine phosphatase prevents STAT1 induction of claudin-2 expression in intestinal epithelial cells.

Authors:  Moorthy Krishnan; Declan F McCole
Journal:  Ann N Y Acad Sci       Date:  2017-08-14       Impact factor: 5.691

Review 3.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

4.  Diminished cytokine signalling against bacterial components in mononuclear leucocytes from ulcerative colitis patients after leukocytapheresis.

Authors:  K Mitsuyama; A Suzuki; S Matsumoto; N Tomiyasu; K Takaki; H Takedatsu; J Masuda; K Handa; K Harada; H Nishida; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

5.  Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.

Authors:  R Ito; M Shin-Ya; T Kishida; A Urano; R Takada; J Sakagami; J Imanishi; M Kita; Y Ueda; Y Iwakura; K Kataoka; T Okanoue; O Mazda
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

Review 6.  Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.

Authors:  Shubha Priyamvada; Rochelle Gomes; Ravinder K Gill; Seema Saksena; Waddah A Alrefai; Pradeep K Dudeja
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

7.  VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects.

Authors:  Moorthy Krishnan; Harrison M Penrose; Nilay N Shah; Ronald R Marchelletta; Declan F McCole
Journal:  Inflamm Bowel Dis       Date:  2016-12       Impact factor: 5.325

8.  AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function.

Authors:  Michael Scharl; Gisela Paul; Kim E Barrett; Declan F McCole
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

9.  Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2.

Authors:  Michael Scharl; Gisela Paul; Achim Weber; Barbara C Jung; Michael J Docherty; Martin Hausmann; Gerhard Rogler; Kim E Barrett; Declan F McCole
Journal:  Gastroenterology       Date:  2009-10-08       Impact factor: 22.682

10.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.